Wells Fargo’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$228K Sell
14,045
-160,368
-92% -$2.84M ﹤0.01% 4630
2025
Q4
$3.26M Buy
174,413
+149,660
+605% +$2.48M ﹤0.01% 3049
2025
Q3
$361K Buy
24,753
+4,258
+21% +$53.8K ﹤0.01% 4536
2025
Q2
$226K Sell
20,495
-1,939
-9% -$18.9K ﹤0.01% 4705
2025
Q1
$200K Buy
22,434
+730
+3% +$6.79K ﹤0.01% 4698
2024
Q4
$204K Buy
21,704
+4,695
+28% +$42.7K ﹤0.01% 4787
2024
Q3
$137K Buy
17,009
+723
+4% +$6.26K ﹤0.01% 4829
2024
Q2
$138K Sell
16,286
-1,564
-9% -$14.1K ﹤0.01% 4752
2024
Q1
$160K Buy
17,850
+1,264
+8% +$11.7K ﹤0.01% 4607
2023
Q4
$186K Buy
16,586
+1,644
+11% +$16.5K ﹤0.01% 4501
2023
Q3
$129K Sell
14,942
-9,466
-39% -$91.4K ﹤0.01% 4626
2023
Q2
$253K Buy
24,408
+10,928
+81% +$121K ﹤0.01% 4434
2023
Q1
$146K Buy
13,480
+12,457
+1,218% +$132K ﹤0.01% 4609
2022
Q4
$11.5K Sell
1,023
-999
-49% -$10.5K ﹤0.01% 5493
2022
Q3
$21K Sell
2,022
-585
-22% -$5.48K ﹤0.01% 5371
2022
Q2
$24K Sell
2,607
-4,835
-65% -$44.6K ﹤0.01% 5366
2022
Q1
$71K Sell
7,442
-22,662
-75% -$222K ﹤0.01% 5486
2021
Q4
$334K Buy
30,104
+14,645
+95% +$128K ﹤0.01% 4975
2021
Q3
$114K Sell
15,459
-173,886
-92% -$1.94M ﹤0.01% 5340
2021
Q2
$2.75M Buy
189,345
+6,480
+4% +$122K ﹤0.01% 3405
2021
Q1
$3.73M Sell
182,865
-89,297
-33% -$1.7M ﹤0.01% 3122
2020
Q4
$4.84M Sell
272,162
-4,624
-2% -$83K ﹤0.01% 2790
2020
Q3
$4.09M Sell
276,786
-4,313
-2% -$80.8K ﹤0.01% 2694
2020
Q2
$5.9M Buy
281,099
+81,190
+41% +$2.09M ﹤0.01% 2316
2020
Q1
$4.62M Buy
199,909
+3,292
+2% +$82.4K ﹤0.01% 2295
2019
Q4
$5.09M Buy
196,617
+41,873
+27% +$814K ﹤0.01% 2552
2019
Q3
$3.01M Buy
154,744
+7,981
+5% +$161K ﹤0.01% 2989
2019
Q2
$2.4M Sell
146,763
-3,558
-2% -$72.1K ﹤0.01% 3188
2019
Q1
$3.41M Buy
150,321
+18,859
+14% +$478K ﹤0.01% 2911
2018
Q4
$3.36M Buy
131,462
+2,642
+2% +$71.3K ﹤0.01% 2829
2018
Q3
$4.21M Buy
128,820
+563
+0.4% +$15.3K ﹤0.01% 2782
2018
Q2
$2.91M Sell
128,257
-8,305
-6% -$197K ﹤0.01% 3145
2018
Q1
$3.31M Buy
136,562
+1,148
+0.8% +$31.5K ﹤0.01% 2954
2017
Q4
$3.78M Buy
135,414
+18,335
+16% +$543K ﹤0.01% 2840
2017
Q3
$4.01M Buy
117,079
+28,391
+32% +$928K ﹤0.01% 2721
2017
Q2
$3.53M Buy
88,688
+56,418
+175% +$2.17M ﹤0.01% 2728
2017
Q1
$1.19M Buy
32,270
+3,100
+11% +$99K ﹤0.01% 3619
2016
Q4
$930K Buy
29,170
+16,337
+127% +$507K ﹤0.01% 3760
2016
Q3
$465K Buy
12,833
+502
+4% +$14K ﹤0.01% 3991
2016
Q2
$280K Buy
12,331
+3,199
+35% +$69.1K ﹤0.01% 4222
2016
Q1
$172K Buy
9,132
+343
+4% +$5.61K ﹤0.01% 4497
2015
Q4
$144K Buy
8,789
+1,608
+22% +$25.5K ﹤0.01% 4673
2015
Q3
$79K Sell
7,181
-5,573
-44% -$71K ﹤0.01% 5052
2015
Q2
$166K Buy
12,754
+5,434
+74% +$84.3K ﹤0.01% 4721
2015
Q1
$127K Buy
7,320
+749
+11% +$13.7K ﹤0.01% 4647
2014
Q4
$97K Sell
6,571
-2,415
-27% -$42.1K ﹤0.01% 4750
2014
Q3
$207K Sell
8,986
-1,128
-11% -$32.7K ﹤0.01% 4340
2014
Q2
$322K Buy
+10,114
New +$304K ﹤0.01% 4138

Other funds holding TBPH